Skip to main content

International Finance Facility for Immunisation: Cost-effectiveness

Volume 472: debated on Monday 3 March 2008

To ask the Chancellor of the Exchequer what assessment his Department has made of the value for money of the International Finance Facility for Immunisation. (168293)

Vaccines are cheap and effective ways of saving lives. Diseases like smallpox, measles, and polio have already been successfully controlled or even eradicated with the help of vaccines. There are strong reasons for frontloading resources for vaccine distribution through the International Finance Facility for Immunisation (IFFIm). When a child is vaccinated, it not only reduces the risk to him/her, but also reduces the risk to others who come in contact with the child, preventing the spread of disease.

The World Health Organisation has estimated that spending $4 billion through IFFIm without frontloading would save an estimated 2.5 million lives before 2015. But by frontloading $4 billion, twice as many lives—an estimated five million—could be saved in the years to 2015, and a further five million afterwards.

Through IFFIm funding, by the end of 2007, an estimated 14.5 million children will have been reached with vaccine against hepatitis B, and 4.4 million children with vaccine against yellow fever—saving the lives of children in the world’s poorest countries.